Survivin is a new inhibitor of apoptosis (IAP) protein. It is expressed in the G2/M phase of the cell cycle in a cycle-regulated manner. The overexpression of surviving in cancer may overcome this apoptotic checkpoint and favor aberrant progression of transformed cells through mitosis.
Immunogen
BIRC5 antibody was raised against a peptide near the N-Terminus of BIRC5 (Human).
Key Feature
Clonality
Polyclonal
Host Species
Rabbit
Tested Applications
IHC
BIRC5 antibody can be used in immunocytochemistry, and immunohistochemistry starting at 10 μg/mL.